MacroPore Announces Japan Prospects, Withdraws Revenue Guidance

MacroPore stands to gain up to $10 mil. in revenue over three years via minimum purchase agreements and royalties from Japanese distribution firm Senko Medical Trading Co., assuming MAST Biosurgery AG does not exercise its option to acquire those rights